Siga Technologies (SIGA) Interest Expenses (2012 - 2020)
Siga Technologies' (SIGA) quarterly Interest Expenses came in at $3.0 million in Q1 2020, down 23.21% on a YoY basis from $3.9 million in Q2 2019, and down 22.61% quarter-over-quarter from $3.9 million in Q4 2019.
Analysis
Siga Technologies (SIGA) Interest Expenses (2012 - 2020) Analysis & Trends
Siga Technologies (SIGA) has reported Interest Expenses for 9 consecutive years, with $3.0 million the latest figure, recorded in Q1 2020.
- For the quarter ending Q1 2020, Interest Expenses fell 23.21% year-over-year to $3.0 million; the trailing twelve-month figure through Dec 2020 stood at $3.0 million (down 80.87% YoY), and the FY2020 full-year result was $3.0 million, down 80.87% from the prior year.
- Interest Expenses declined to $3.0 million in Q1 2020 per SIGA's latest filing, from $3.9 million in the prior quarter.
- Across five years, Interest Expenses topped out at $4.0 million in Q3 2019 and bottomed at $10214.0 in Q2 2016.
- Historically, Interest Expenses has averaged $3.2 million across 5 years, with a median of $3.8 million in 2017.
- The sharpest annual moves came in 2016 and 2017: Interest Expenses dropped 23.29% in 2016, then soared 35659.7% in 2017.
- Over 5 years, Interest Expenses stood at $2.3 million in 2016, then surged by 64.25% to $3.8 million in 2017, then advanced by 5.31% to $4.0 million in 2018, then decreased by 1.61% to $3.9 million in 2019, then slipped by 22.61% to $3.0 million in 2020.
- According to Business Quant data, Interest Expenses over the past three periods registered $3.0 million, $3.9 million, and $4.0 million for Q1 2020, Q4 2019, and Q3 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 23.78 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 2.90 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 3.02 Mn |
| Dec 31, 2019 | 3.90 Mn |
| Sep 30, 2019 | 3.97 Mn |
| Jun 30, 2019 | 3.97 Mn |
| Mar 31, 2019 | 3.93 Mn |
| Dec 31, 2018 | 3.96 Mn |
| Sep 30, 2018 | 3.92 Mn |
| Jun 30, 2018 | 3.84 Mn |
| Mar 31, 2018 | 3.75 Mn |
| Dec 31, 2017 | 3.76 Mn |
| Sep 30, 2017 | 3.74 Mn |
| Jun 30, 2017 | 3.65 Mn |
| Mar 31, 2017 | 3.61 Mn |
| Dec 31, 2016 | 2.29 Mn |
| Sep 30, 2016 | 94,776.00 |
| Jun 30, 2016 | 10,214.00 |
| Jun 30, 2015 | 13,315.00 |
| Mar 31, 2015 | 253,412.00 |
| Dec 31, 2014 | 86,223.00 |
| Sep 30, 2014 | 105,149.00 |